Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Johal
THU0725-HPR Cost Effectiveness Analysis of Abatacept Compared With TNF Inhibitors in Patients Who Are Positive for Anti-Citrullinated Protein Antibodies Based on Results From an Observational Trial
Related publications
Cost-Effectiveness of Abatacept, Tocilizumab and TNF-inhibitors Compared With Rituximab as Second-Line Biologic Drug in Rheumatoid Arthritis
PLoS ONE
Multidisciplinary
How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies–positive Patients Who Do Not Have Arthritis?
Journal of Rheumatology
Rheumatology
Allergy
Immunology
A8.2 Anti Citrullinated Protein Antibodies From Synovial Fluid of Rheumatoid Arthritis Patients Enhance Osteoclastogenesis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
FRI0213 Comparative Effectiveness of Abatacept, Rituximab, Tocilizumab and Anti-TNF Biological Dmards in Ra: Results From the Nationwide Swedish Register
Anti-Citrullinated Peptide Antibodies May Occur in Patients With Psoriatic Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Anti-Cyclic Citrullinated Peptide Antibodies in Patients With Primary Sjogren's Syndrome
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Pdb62 - Cost-Effectiveness Analysis of Empagliflozin in Japan Based on Results From the Subgroup Analysis of Asian Patients in the Empa-Reg Outcome Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Structural Basis of Cross-Reactivity of Anti-Citrullinated Protein Antibodies
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
P018 Anti-Carbamylated Protein Antibodies as a Clinical Response Predictor in Rheumatoid Arthritis Patients Treated With Abatacept
